Immunovant, Inc. (IMVT) Insider Trading

Name: Immunovant, Inc. (IMVT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 5, 2026): Eric Venker (Chief Executive Officer): Exercise/Conversion of 92,187 shares, $1.33M.

Get alerted when insiders trade IMVT

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta